Maximilian Bielohuby und Sanofi - Info zur Person

(1 - 13 von 18

)

Norbert Tennagels und Maximilian BielohubySanofi in Deutschland

www.sanofi.de

Adventskalender von Sanofi in Deutschland 2019: Türchen Nummer 17 mit Norbert Tennagels und Maximilian Bielohuby: Auktion für den guten Zweck.

Maximilian Bielohuby - Loop (Frontiers)loop.frontiersin.org › people › bio

loop.frontiersin.org

Maximilian Bielohuby. Habilitation. Sanofi (France). Paris, France. View All. mini profile avatar Maximilian Bielohuby.

9-PAHSA displays a weak anti-inflammatory potential ...Directory of Open Access Journals

doaj.org

Maximilian Bielohuby. Affiliations. Paulus Wohlfart: Sanofi, Industriepark Höchst, Frankfurt, Germany; Mounir Chehtane: Sanofi, Orlando, FL, United States ... Maximilian Bielohuby. Affiliations. Paulus Wohlfart: Sanofi, Industriepark Höchst, Frankfurt, Germany; Mounir Chehtane: Sanofi, Orlando, FL, United States ...

Gastrointestinal Hormonesbooks.google.com.pa › books

books.google.com.pa

published: 04 January doi: fendo Edited by: Maximilian Bielohuby, Sanofi, France Reviewed by: Yoshio Fujitani, Gunma University, ...

Preclinical pharmacology of RA : In vitro and in vivo ...Wiley

dom-pubs.onlinelibrary.wiley.com

von U Werner · — Ulrich Werner and Maximilian Bielohuby were employees of Sanofi at the time of the analysis. Maximilian Bielohuby is now an employee of CSL ... von U Werner · — Ulrich Werner and Maximilian Bielohuby were employees of Sanofi at the time of the analysis. Maximilian Bielohuby is now an employee of CSL ...

The Regulation of Peripheral Metabolism by Gut-Derived ...ReadCube

www.readcube.com

Maximilian Bielohuby,. Sanofi, France. Reviewed by: Yoshio Fujitani,. Gunma University, Japan. Andreas Hoeflich,. Leibniz Institute for Farm Animal. Biology ... Maximilian Bielohuby,. Sanofi, France. Reviewed by: Yoshio Fujitani,. Gunma University, Japan. Andreas Hoeflich,. Leibniz Institute for Farm Animal. Biology ...

Control of (pre)-analytical aspects in immunoassay ...Endocrine Connections

ec.bioscientifica.com

von M Bielohuby · · Zitiert von: 8 — ... Maximilian Bielohuby. Maximilian Bielohuby Sanofi-Aventis Deutschland GmbH, R&D, Industriepark Höchst, Frankfurt, Germany Search for other papers by ... von M Bielohuby · · Zitiert von: 8 — ... Maximilian Bielohuby. Maximilian Bielohuby Sanofi-Aventis Deutschland GmbH, R&D, Industriepark Höchst, Frankfurt, Germany Search for other papers by ...

In vitro and in vivo activity of a novel ultralong-acting basal ...National Institutes of Health (NIH) (.gov)

pubmed.ncbi.nlm.nih.gov

von U Werner · — Maximilian Bielohuby , Marcus Korn , Jens Riedel , Martin Will , María Méndez. Affiliations. 1 Sanofi, R&D, TD Diabetes, Industriepark Hoechst ... von U Werner · — Maximilian Bielohuby , Marcus Korn , Jens Riedel , Martin Will , María Méndez. Affiliations. 1 Sanofi, R&D, TD Diabetes, Industriepark Hoechst ...

Nearly a Century of Insulin at Sanofi: Looking Back Over ...Pediatric Endocrinology Reviews

www.pediatricendoreviews.com

... and Development. Authors: Zsolt Bosnyak, MD, PhD, Marcus Korn, PhD, Maximilian Bielohuby, PhD, Paulus Wohlfart, PhD, Norbert Tennagels, PhD. Publisher: and Development. Authors: Zsolt Bosnyak, MD, PhD, Marcus Korn, PhD, Maximilian Bielohuby, PhD, Paulus Wohlfart, PhD, Norbert Tennagels, PhD. Publisher: ,00 $

Pediatric Endocrinology Reviews : PERRead by QxMD

read.qxmd.com

Nearly a Century of Insulin at Sanofi: Looking Back Over the Decades of Production and Development. Zsolt Bosnyak, Marcus Korn, Maximilian Bielohuby, Paulus ... Nearly a Century of Insulin at Sanofi: Looking Back Over the Decades of Production and Development. Zsolt Bosnyak, Marcus Korn, Maximilian Bielohuby, Paulus ...

The role of C16:0 ceramide in the development of obesity ...Europe PMC

europepmc.org

von S Raichur · · Zitiert von: 169 — Maximilian Bielohuby. 1Sanofi-Aventis Deutschland GmbH, TA Diabetes, Industriepark Höchst, D Frankfurt am Main, Germany. Find articles by Maximilian ... von S Raichur · · Zitiert von: 169 — Maximilian Bielohuby. 1Sanofi-Aventis Deutschland GmbH, TA Diabetes, Industriepark Höchst, D Frankfurt am Main, Germany. Find articles by Maximilian ...

In vitro and in vivo activity of a novel ultralong-acting basal ...X-MOL

www.x-mol.com

— Ulrich Werner 1 , Maximilian Bielohuby 1 , Marcus Korn 1 , Jens Riedel 2 , Martin Will 3 , María Méndez 3. Affiliation. Sanofi, R&D, TD — Ulrich Werner 1 , Maximilian Bielohuby 1 , Marcus Korn 1 , Jens Riedel 2 , Martin Will 3 , María Méndez 3. Affiliation. Sanofi, R&D, TD ...

Control of (pre)-analytical aspects in immunoassay ...National Institutes of Health (.gov)

pubmed.ncbi.nlm.nih.gov

von M Bielohuby · · Zitiert von: 8 — Maximilian Bielohuby , Martin Bidlingmaier , Uwe Schwahn. Affiliations. 1 Sanofi-Aventis Deutschland GmbHR&D, Industriepark Höchst, Frankfurt, Germany ...

Alle Infos zum Namen "Maximilian Bielohuby"

Verwandte Suchanfragen zu Maximilian Bielohuby

Angela Doering
Nadja Herbach
Henri Wallaschofski

Dominik Menhofer
Thomas Fleming
Jenny Manolopoulou

Martin Bidlingmaier
Mandy Sawitzky
Sage Journals

Personen
Vorname "Maximilian" (16070)
Name "Bielohuby" (4)

sortiert nach Relevanz / Datum

Erweiterte Suche

Person-Suchen: A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Maximilian Bielohuby und Sanofi Person-Info